Complementary and Alternative Medicine for Liver Diseases

Author:

Yu Chun-Hsien12,Lin Ya-Hsuan3,Cheng Ching-Feng124,Kuo Chan-Yen5

Affiliation:

1. Department of Pediatrics, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei 23142, Taiwan;

2. Department of Pediatrics, School of Medicine, Tzu Chi University, Hualien 97071, Taiwan;

3. Department of Chinese Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan;

4. Institute of Biomedical Sciences, Academia Sinica, Taipei City 115201,Taiwan; and

5. Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan

Abstract

Fibrosis in the liver can result in portal hypertension and structural changes, eventually progressing to cirrhosis or hepatocellular carcinoma. Liver fibrosis is caused by the activation of liver hepatic stellate cells. Treatment of liver fibrosis may involve the induction of apoptosis or prevention of activation of activated hepatic stellate cells. A novel therapeutic strategy for treating liver fibrosis caused by hepatic stellate cells may be developed through complementary and alternative therapies. Therefore, in this article, we discuss recent investigations into the complementary and alternative medicine as a means of preventing and treating liver fibrosis.

Publisher

New Century Health Publishers LLC

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3